Cargando…

Management of Hepatic Granulomatous Tuberculosis After BCG Therapy for Bladder Cancer

BCG therapy is used as a treatment in bladder cancer. Intravesical administration of Bacillus Calmette-Guérin is used as a treatment method in superficial bladder cancer. While it is commonly effective, some serious side effects may occur. We hereby report a 65-year-old man who developed granulomato...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayati, Mohsen, Nowroozi, Mohammad Reza, Mortazavi, Afshin, Ohadian Moghadam, Solmaz, Ghorani, Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447372/
https://www.ncbi.nlm.nih.gov/pubmed/28567336
http://dx.doi.org/10.1016/j.eucr.2017.04.011
_version_ 1783239326646140928
author Ayati, Mohsen
Nowroozi, Mohammad Reza
Mortazavi, Afshin
Ohadian Moghadam, Solmaz
Ghorani, Hossein
author_facet Ayati, Mohsen
Nowroozi, Mohammad Reza
Mortazavi, Afshin
Ohadian Moghadam, Solmaz
Ghorani, Hossein
author_sort Ayati, Mohsen
collection PubMed
description BCG therapy is used as a treatment in bladder cancer. Intravesical administration of Bacillus Calmette-Guérin is used as a treatment method in superficial bladder cancer. While it is commonly effective, some serious side effects may occur. We hereby report a 65-year-old man who developed granulomatous hepatitis as a complication following BCG therapy. He was treated successfully with antitubercular therapy and prednisolone.
format Online
Article
Text
id pubmed-5447372
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-54473722017-05-31 Management of Hepatic Granulomatous Tuberculosis After BCG Therapy for Bladder Cancer Ayati, Mohsen Nowroozi, Mohammad Reza Mortazavi, Afshin Ohadian Moghadam, Solmaz Ghorani, Hossein Urol Case Rep Oncology BCG therapy is used as a treatment in bladder cancer. Intravesical administration of Bacillus Calmette-Guérin is used as a treatment method in superficial bladder cancer. While it is commonly effective, some serious side effects may occur. We hereby report a 65-year-old man who developed granulomatous hepatitis as a complication following BCG therapy. He was treated successfully with antitubercular therapy and prednisolone. Elsevier 2017-05-25 /pmc/articles/PMC5447372/ /pubmed/28567336 http://dx.doi.org/10.1016/j.eucr.2017.04.011 Text en © 2017 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Oncology
Ayati, Mohsen
Nowroozi, Mohammad Reza
Mortazavi, Afshin
Ohadian Moghadam, Solmaz
Ghorani, Hossein
Management of Hepatic Granulomatous Tuberculosis After BCG Therapy for Bladder Cancer
title Management of Hepatic Granulomatous Tuberculosis After BCG Therapy for Bladder Cancer
title_full Management of Hepatic Granulomatous Tuberculosis After BCG Therapy for Bladder Cancer
title_fullStr Management of Hepatic Granulomatous Tuberculosis After BCG Therapy for Bladder Cancer
title_full_unstemmed Management of Hepatic Granulomatous Tuberculosis After BCG Therapy for Bladder Cancer
title_short Management of Hepatic Granulomatous Tuberculosis After BCG Therapy for Bladder Cancer
title_sort management of hepatic granulomatous tuberculosis after bcg therapy for bladder cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447372/
https://www.ncbi.nlm.nih.gov/pubmed/28567336
http://dx.doi.org/10.1016/j.eucr.2017.04.011
work_keys_str_mv AT ayatimohsen managementofhepaticgranulomatoustuberculosisafterbcgtherapyforbladdercancer
AT nowroozimohammadreza managementofhepaticgranulomatoustuberculosisafterbcgtherapyforbladdercancer
AT mortazaviafshin managementofhepaticgranulomatoustuberculosisafterbcgtherapyforbladdercancer
AT ohadianmoghadamsolmaz managementofhepaticgranulomatoustuberculosisafterbcgtherapyforbladdercancer
AT ghoranihossein managementofhepaticgranulomatoustuberculosisafterbcgtherapyforbladdercancer